Citation: D. Wallach, WHY IS THE CAUSE OF A CONSPICUOUS DISEASE SUCH AS PITYRIASIS ROSEA NOT KNOWN, Annales de dermatologie et de venereologie, 124(11), 1997, pp. 784-785
Authors:
DECARSALADE GY
WALLACH D
SPINDLER E
PENNEC J
COTTENOT F
FLAGEUL B
Citation: Gy. Decarsalade et al., DAILY MULTIDRUG THERAPY FOR LEPROSY - RESULTS OF A 14-YEAR EXPERIENCE, International journal of leprosy and other mycobacterial diseases, 65(1), 1997, pp. 37-44
Authors:
GOLTSEV YV
KOVALENKO AV
ARNOLD E
VARFOLOMEEV EE
BRODIANSKII VM
WALLACH D
Citation: Yv. Goltsev et al., CASH, A NOVEL CASPASE HOMOLOG WITH DEATH EFFECTOR DOMAINS, The Journal of biological chemistry, 272(32), 1997, pp. 19641-19644
Authors:
WALLACH D
BOLDIN M
VARFOLOMEEV E
BEYAERT R
VANDENABEELE P
FIERS W
Citation: D. Wallach et al., CELL-DEATH INDUCTION BY RECEPTORS OF THE TNF FAMILY - TOWARDS A MOLECULAR UNDERSTANDING, FEBS letters, 410(1), 1997, pp. 96-106
Citation: D. Wallach, A DECADE OF ACCUMULATED KNOWLEDGE AND EMERGING ANSWERS - THE 6TH INTERNATIONAL-CONGRESS ON TNF - RHODES, GREECE - MAY 1996, European cytokine network, 7(4), 1996, pp. 713-724
Citation: R. Eliaz et al., LONG-TERM PROTECTION AGAINST THE EFFECTS OF TUMOR-NECROSIS-FACTOR BY CONTROLLED DELIVERY OF THE SOLUBLE P55 TNF RECEPTOR, Cytokine, 8(6), 1996, pp. 482-487
Authors:
SHOHAMI E
BASS R
WALLACH D
YAMIN A
GALLILY R
Citation: E. Shohami et al., INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) ACTIVITY IN RAT-BRAIN IS ASSOCIATED WITH CEREBROPROTECTION AFTER CLOSED-HEAD INJURY, Journal of cerebral blood flow and metabolism, 16(3), 1996, pp. 378-384
Authors:
BOLDIN MP
GONCHAROV TM
GOLTSEV YV
WALLACH D
Citation: Mp. Boldin et al., INVOLVEMENT OF MACH, A NOVEL MORT1 FADD-INTERACTING PROTEASE, IN FAS/APO-1-INDUCED AND TNF RECEPTOR-INDUCED CELL-DEATH/, Cell, 85(6), 1996, pp. 803-815
Authors:
KUPFERMINC MJ
PEACEMAN AM
ADERKA D
WALLACH D
SOCOL ML
Citation: Mj. Kupferminc et al., SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS AND INTERLEUKIN-6 LEVELS IN PATIENTS WITH SEVERE PREECLAMPSIA, Obstetrics and gynecology, 88(3), 1996, pp. 420-427
Authors:
TURKASPA I
MAOR Y
WEISSENBERG R
MADGAR I
ADERKA D
DOR J
MASHIACH S
WALLACH D
Citation: I. Turkaspa et al., HIGH-LEVELS OF SOLUBLE P55-TNF RECEPTORS IN SEMINAL AND PROSTATIC FLUIDS OF NORMAL AND INFERTILE MEN, The Journal of urology, 155(4), 1996, pp. 1436-1438
Authors:
VARFOLOMEEV EE
BOLDIN MP
GONCHAROV TM
WALLACH D
Citation: Ee. Varfolomeev et al., A POTENTIAL MECHANISM OF CROSS-TALK BETWEEN THE P55 TUMOR-NECROSIS-FACTOR RECEPTOR AND FAS APO1 - PROTEINS BINDING TO THE DEATH DOMAINS OF THE 2 RECEPTORS ALSO BIND TO EACH OTHER/, The Journal of experimental medicine, 183(3), 1996, pp. 1271-1275
Citation: Md. Vignonpennamen et D. Wallach, NEUTROPHILIC DISEASE - A REVIEW OF EXTRACUTANEOUS NEUTROPHILIC MANIFESTATIONS, EJD. European journal of dermatology, 5(6), 1995, pp. 449-455
Authors:
KALINKOVICH A
GELEZIUNAS R
KEMPER O
BELENKI D
WALLACH D
WAINBERG MA
BENTWICH Z
Citation: A. Kalinkovich et al., INCREASED SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR EXPRESSION AND RELEASE BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, Journal of interferon & cytokine research, 15(9), 1995, pp. 749-757
Citation: E. Pocsik et al., PHOSPHORYLATION OF THE 26 KDA TNF PRECURSOR IN MONOCYTIC CELLS AND INTRANSFECTED HELA-CELLS, Journal of inflammation, 45(3), 1995, pp. 152-160
Citation: Bd. Sippy et al., INCREASED EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA RECEPTORS IN THE BRAINS OF PATIENTS WITH AIDS, Journal of acquired immune deficiency syndromes and human retrovirology, 10(5), 1995, pp. 511-521
Authors:
FEINSTEIN E
KIMCHI A
WALLACH D
BOLDIN M
VARFOLOMEEV E
Citation: E. Feinstein et al., THE DEATH DOMAIN - A MODULE SHARED BY PROTEINS WITH DIVERSE CELLULAR FUNCTIONS, Trends in biochemical sciences, 20(9), 1995, pp. 342-344
Authors:
OPSJON SL
NOVICK D
WATHEN NC
COPE AP
WALLACH D
ADERKA D
Citation: Sl. Opsjon et al., SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS AND SOLUBLE INTERLEUKIN-6 RECEPTOR IN FETAL AND MATERNAL SERA, CELOMIC AND AMNIOTIC FLUIDS IN NORMAL AND PREECLAMPTIC PREGNANCIES, Journal of reproductive immunology, 29(2), 1995, pp. 119-134
Authors:
PORAT R
PADDOCK HN
SCHWAITZBERG SD
CONNOLLY RJ
WILKENS T
DASCH JR
GASCON MP
HUTCHISON JS
YTHIER A
WALLACH D
DINARELLO CA
Citation: R. Porat et al., GLYCOSYLATED RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR BINDING PROTEIN-1 REDUCES MORTALITY, SHOCK, AND PRODUCTION OF TUMOR-NECROSIS-FACTOR INRABBIT ESCHERICHIA-COLI SEPSIS, Critical care medicine, 23(6), 1995, pp. 1080-1089